Manipulating Thymic Apoptosis for Future Therapy of Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|29|3108-3119

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.29, 2011-10, pp. : 3108-3119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis modulators in the therapy of neurodegenerative diseases

By Deigner H-P.   Haberkorn U.   Kinscherf R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

B-Cell Based Gene Therapy for Autoimmune Diseases

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 3, 2012-06 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Strategies Towards Immune Tolerance to Treat the Autoimmune Diseases

By  

Current Gene Therapy, Vol. 6, Iss. 1, 2006-02 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

By Ahmed A Razzaque  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1019-1032

Informa Healthcare

Access to resources Recommend Favorite

The Evolving Therapy of Rheumatic Diseases, The Future is Now

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite